JoVE Logo

S'identifier

3.4 : Drug Absorption: Factors Affecting GI Absorption

The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.

In contrast, the intestinal villi offer a much larger surface area for absorption, which, combined with high blood flow, makes the intestine a prime site for drug absorption. Furthermore, food in the stomach can interfere with absorption, where drugs can form complexes with food constituents. Additionally, food can delay gastric emptying, or the movement of drugs into the small intestine, further slowing down absorption. Certain physiological conditions, such as diarrhea, can also impact drug absorption by accelerating the movement of gut contents. Lastly, the gut epithelium, which contains P-glycoprotein transporters, can pump drugs back into the gut lumen, reducing their absorption into the blood.

Tags

Drug AbsorptionGastrointestinal AbsorptionWeakly Acidic DrugsNonionized StateIntestinal VilliSurface AreaGastric EmptyingFood InteractionsP glycoprotein TransportersPhysiological ConditionsGut Epithelium

Du chapitre 3:

article

Now Playing

3.4 : Drug Absorption: Factors Affecting GI Absorption

Pharmacokinetics

3.8K Vues

article

3.1 : Pharmacocinétique : Vue d’ensemble

Pharmacokinetics

5.4K Vues

article

3.2 : Mécanisme d’absorption du médicament : transport membranaire passif

Pharmacokinetics

3.5K Vues

article

3.3 : Mécanisme d’absorption du médicament : transport membranaire médié par le transporteur

Pharmacokinetics

3.5K Vues

article

3.5 : Biodisponibilité : Vue d’ensemble

Pharmacokinetics

2.6K Vues

article

3.6 : Facteurs influençant la biodisponibilité : élimination au premier passage

Pharmacokinetics

6.1K Vues

article

3.7 : Bioéquivalence : Vue d’ensemble

Pharmacokinetics

912 Vues

article

3.8 : Effet de premier passage

Pharmacokinetics

5.0K Vues

article

3.9 : Évolution temporelle de l’effet du médicament

Pharmacokinetics

1.9K Vues

article

3.10 : Distribution du médicament : liaison tissulaire

Pharmacokinetics

2.5K Vues

article

3.11 : Barrières physiologiques

Pharmacokinetics

3.4K Vues

article

3.12 : Distribution du médicament : liaison aux protéines plasmatiques

Pharmacokinetics

4.8K Vues

article

3.13 : Modèles à compartiments : Modèle à compartiment unique

Pharmacokinetics

2.1K Vues

article

3.14 : Modèles à compartiments : Modèle à deux compartiments

Pharmacokinetics

5.1K Vues

article

3.15 : Distribution des médicaments : Volume de distribution

Pharmacokinetics

4.4K Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.